RxDoctor Payments Data

Amy Strohmaier, PA

Physician Assistant · Winter Haven, FLNPI 1386880771

Payments from drug & device makers

$4,413in general payments, 2019–2025

Across 116 payments — averaging $38.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$2K
  • Regeneron Healthcare Solutions, Inc.$868
  • AbbVie$242
  • Pfizer$229
  • Sun Pharmaceutical Industries Inc.$126
  • Novartis$105
  • plus $403 from 9 others

What the payments were for

  • Consulting fees$90020%
  • Travel & lodging$1233%
  • Food & beverage$3,02369%
  • Education$3678%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,413 in reported general payments places this provider in the 85th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$94,429
Medicare patients
217
Services billed
1,953

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab110$429,440
TremfyaGuselkumab13$173,362
OtezlaApremilast24$118,543
Fluocinolone Acetonide143$8,410
Clobetasol Propionate203$7,496
Ketoconazole443$6,999
Levocetirizine Dihydrochloride266$3,603
Doxycycline Hyclate195$3,255
Ammonium Lactate117$2,847
Triamcinolone Acetonide272$2,323
Tacrolimus11$1,879
Tretinoin34$1,791
Metronidazole27$1,293
Hydrocortisone263$1,285
Fluocinolone AcetonideFluocinolone/Shower Cap20$1,191

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonTremfya$2,440$173,36213 claims
AmgenOtezla$12$118,54324 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Winter Haven

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →